Compile Data Set for Download or QSAR
maximum 50k data
Found 182 with Last Name = 'zitt' and Initial = 'c'
TargetCannabinoid receptor 2(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402859(CHEMBL2205591)
Affinity DataKi:  81.5nMAssay Description:Displacement of [3H]-CP55,940 from human CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402858(CHEMBL2205592)
Affinity DataKi:  240nMAssay Description:Displacement of [3H]-CP55,940 from human CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402864(CHEMBL2205615)
Affinity DataKi:  241nMAssay Description:Displacement of [3H]-CP55,940 from human CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402863(CHEMBL2205616)
Affinity DataKi:  347nMAssay Description:Displacement of [3H]-CP55,940 from human CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402857(CHEMBL2205593)
Affinity DataKi:  444nMAssay Description:Displacement of [3H]-CP55,940 from human CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402859(CHEMBL2205591)
Affinity DataKi:  594nMAssay Description:Displacement of [3H]-CP55,940 from rat CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402857(CHEMBL2205593)
Affinity DataKi:  630nMAssay Description:Displacement of [3H]-CP55,940 from rat CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402860(CHEMBL2205588)
Affinity DataKi:  899nMAssay Description:Displacement of [3H]-CP55,940 from human CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402861(CHEMBL2205584)
Affinity DataKi:  904nMAssay Description:Displacement of [3H]-CP55,940 from human CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402862(CHEMBL2205620)
Affinity DataKi:  999nMAssay Description:Displacement of [3H]-CP55,940 from human CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402864(CHEMBL2205615)
Affinity DataKi:  1.61E+3nMAssay Description:Displacement of [3H]-CP55,940 from rat CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402861(CHEMBL2205584)
Affinity DataKi:  1.70E+3nMAssay Description:Displacement of [3H]-CP55,940 from rat CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402863(CHEMBL2205616)
Affinity DataKi:  2.13E+3nMAssay Description:Displacement of [3H]-CP55,940 from rat CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402862(CHEMBL2205620)
Affinity DataKi:  2.54E+3nMAssay Description:Displacement of [3H]-CP55,940 from rat CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402860(CHEMBL2205588)
Affinity DataKi:  3.11E+3nMAssay Description:Displacement of [3H]-CP55,940 from rat CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402858(CHEMBL2205592)
Affinity DataKi:  4.62E+3nMAssay Description:Displacement of [3H]-CP55,940 from rat CB2 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402859(CHEMBL2205591)
Affinity DataKi:  7.19E+3nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402857(CHEMBL2205593)
Affinity DataKi:  1.11E+4nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402864(CHEMBL2205615)
Affinity DataKi:  1.17E+4nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402857(CHEMBL2205593)
Affinity DataKi:  1.35E+4nMAssay Description:Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402864(CHEMBL2205615)
Affinity DataKi:  1.51E+4nMAssay Description:Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402863(CHEMBL2205616)
Affinity DataKi:  1.94E+4nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402863(CHEMBL2205616)
Affinity DataKi:  2.26E+4nMAssay Description:Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402861(CHEMBL2205584)
Affinity DataKi: >3.00E+4nMAssay Description:Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402860(CHEMBL2205588)
Affinity DataKi: >3.00E+4nMAssay Description:Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402859(CHEMBL2205591)
Affinity DataKi: >3.00E+4nMAssay Description:Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402858(CHEMBL2205592)
Affinity DataKi: >3.00E+4nMAssay Description:Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402862(CHEMBL2205620)
Affinity DataKi: >3.00E+4nMAssay Description:Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402862(CHEMBL2205620)
Affinity DataKi: >3.00E+4nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402861(CHEMBL2205584)
Affinity DataKi: >3.00E+4nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402860(CHEMBL2205588)
Affinity DataKi: >3.00E+4nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Nycomed Pharma

Curated by ChEMBL
LigandPNGBDBM50402858(CHEMBL2205592)
Affinity DataKi: >3.00E+4nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor after 60 mins by microscintillation counting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180790(US8865745, 14)
Affinity DataIC50:  0.870nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM60633(US8865745, 8)
Affinity DataIC50:  2.95nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180793(US8865745, 18)
Affinity DataIC50:  3.80nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180779(US8865745, 1)
Affinity DataIC50:  5.13nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM60635(US8865745, 17)
Affinity DataIC50:  5.37nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180795(US8865745, 20)
Affinity DataIC50:  5.75nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM60634(US8865745, 9)
Affinity DataIC50:  5.89nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180780(US8865745, 2)
Affinity DataIC50:  8.13nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180787(US8865745, 11)
Affinity DataIC50:  8.32nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180791(US8865745, 15)
Affinity DataIC50:  12.6nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180789(US8865745, 13)
Affinity DataIC50:  16.2nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180781(US8865745, 3)
Affinity DataIC50:  17.8nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180782(US8865745, 4)
Affinity DataIC50:  18.2nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180785(US8865745, 7)
Affinity DataIC50:  22.4nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180794(US8865745, 19)
Affinity DataIC50:  33.1nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180792(US8865745, 16)
Affinity DataIC50:  33.1nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180788(US8865745, 12)
Affinity DataIC50:  34.7nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Takeda

US Patent
LigandPNGBDBM180783(US8865745, 5)
Affinity DataIC50:  70.8nMpH: 7.4 T: 2°CAssay Description:PDE4B1 activity was inhibited by the compounds according to the invention in a modified SPA (scintillation proximity assay) test, supplied by Amersha...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 182 total ) | Next | Last >>
Jump to: